Search Results - "Tavecchia, Luisa"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2
  3. 3

    A case of beta-thalassaemia major resistant to standard treatment by Masera, Nicoletta, Decimi, Valentina, Tavecchia, Luisa, Capra, Marietta, Cazzaniga, Giovanni, Biondi, Andrea, Masera, Giuseppe

    Published in Clinical management issues (15-06-2010)
    “…We report the case of a 22-year-old woman from Albania, with thalassaemia major, in severe clinical condition who could no longer be transfused due to the…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Successful recovery of acute hemosiderotic heart failure in beta-thalassemia major treated with a combined regimen of desferrioxamine and deferiprone by Tavecchia, Luisa, Masera, Nicoletta, Russo, Pierluigi, Cirò, Antonio, Vincenzi, Antonella, Vimercati, Chiara, Masera, Giuseppe

    Published in Haematologica (Roma) (01-06-2006)
    “…We report the case of a 25-years-old male with beta-thalassemia major who developed acute heart failure, with severe systolic dysfunction, resulting from iron…”
    Get full text
    Journal Article
  7. 7

    GH deficiency in adult B-thalassemia major patients and its relationship with IGF-1 production by Pincelli, Angela Ida, Masera, Nicoletta, Tavecchia, Luisa, Perotti, Mario, Perra, Silvia, Mariani, Raffaela, Piperno, Alberto, Mancia, Giuseppe, Grassi, Guido, Masera, Giuseppe

    Published in Pediatric endocrinology reviews : PER (01-03-2011)
    “…Endocrine complications in Β-thalassemia represent a prominent cause of morbidity. Above all, dysfunction of GH-IGF-1 axis is of a major concern because of its…”
    Get more information
    Journal Article
  8. 8

    Periodic erythroexchange is an effective strategy for high risk paediatric patients with sickle-cell disease by Masera, Nicoletta, Tavecchia, Luisa, Pozzi, Lorena, Riva, Francesca, Vimercati, Chiara, Calabria, Manuela, Ronzoni, Simona, Masera, Giuseppe, Perseghin, Paolo

    Published in Transfusion and apheresis science (01-12-2007)
    “…Abstract We performed an 11 year retrospective study on 34 sickle-cell paediatric patients, focusing on efficacy, safety and costs of an exchange transfusion…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Serum Level of the Soluble Form of the CD30 Molecule Identifies Patients With Hodgkin’s Disease at High Risk of Unfavorable Outcome by Nadali, Gianpaolo, Tavecchia, Luisa, Zanolin, Elisabetta, Bonfante, Valeria, Viviani, Simonetta, Camerini, Edgarda, Musto, Pellegrino, Di Renzo, Nicola, Carotenuto, Mario, Chilosi, Marco, Krampera, Mauro, Pizzolo, Giovanni

    Published in Blood (15-04-1998)
    “…Preliminary reports suggested a prognostic significance for serum levels of soluble CD30 (sCD30) in patients with Hodgkin’s disease (HD). In this study, we…”
    Get full text
    Journal Article
  11. 11

    Regulation of the proliferative potential of cord blood long-term culture-initiating cells (LTC-IC) by different stromal cell lines: implications for LTC-IC measurement by Nadali, G, de Wynter, EA, Perandin, F, Tavecchia, L, Vincenzi, C, Ambrosetti, A, Fornale, M, Perona, G, Pizzolo, G, Testa, NG

    Published in Haematologica (Roma) (01-12-1998)
    “…Department of Hematology, University of Verona, Italy. gnadali@borgoroma.univr.it BACKGROUND AND OBJECTIVE: Long-term culture-initiating cells (LTC-IC) are the…”
    Get full text
    Journal Article